Modrof J - Search Results

1

Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes.

Farcet MR, Lackner C, Antoine G, Rabel PO, Wieser A, Flicker A, Unger U, Modrof J, Kreil TR. Farcet MR, et al. Among authors: modrof j. Transfusion. 2016 Feb;56(2):383-91. doi: 10.1111/trf.13343. Epub 2015 Sep 24. Transfusion. 2016. PMID: 26399175

2

West Nile virus neutralization by US plasma-derived immunoglobulin products.

Planitzer CB, Modrof J, Kreil TR. Planitzer CB, et al. Among authors: modrof j. J Infect Dis. 2007 Aug 1;196(3):435-40. doi: 10.1086/519392. Epub 2007 Jun 18. J Infect Dis. 2007. PMID: 17597458

3

Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.

Modrof J, Berting A, Tille B, Klotz A, Forstner C, Rieger S, Aberham C, Gessner M, Kreil TR. Modrof J, et al. Transfusion. 2008 Jan;48(1):178-86. doi: 10.1111/j.1537-2995.2007.01503.x. Epub 2007 Sep 27. Transfusion. 2008. PMID: 17900278

4

Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates.

Berting A, Modrof J, Unger U, Gessner M, Klotz A, Poelsler G, Kreil TR. Berting A, et al. Among authors: modrof j. Transfusion. 2008 Jun;48(6):1220-6. doi: 10.1111/j.1537-2995.2008.01662.x. Epub 2008 Apr 10. Transfusion. 2008. PMID: 18410254

5

Virus inactivation during the freeze-drying processes as used for the manufacture of plasma-derived medicinal products.

Unger U, Poelsler G, Modrof J, Kreil TR. Unger U, et al. Among authors: modrof j. Transfusion. 2009 Sep;49(9):1924-30. doi: 10.1111/j.1537-2995.2009.02218.x. Epub 2009 May 19. Transfusion. 2009. PMID: 19453977

6

West Nile virus infection in plasma of blood and plasma donors, United States.

Planitzer CB, Modrof J, Yu MY, Kreil TR. Planitzer CB, et al. Among authors: modrof j. Emerg Infect Dis. 2009 Oct;15(10):1668-70. doi: 10.3201/eid1510.081668. Emerg Infect Dis. 2009. PMID: 19861071 Free PMC article.

7

Hepatitis A virus antibodies in immunoglobulin preparations.

Farcet MR, Planitzer CB, Stein O, Modrof J, Kreil TR. Farcet MR, et al. Among authors: modrof j. J Allergy Clin Immunol. 2010 Jan;125(1):198-202. doi: 10.1016/j.jaci.2009.09.008. Epub 2009 Dec 4. J Allergy Clin Immunol. 2010. PMID: 19962745

8

Inactivation of hepatitis A variants during heat treatment (pasteurization) of human serum albumin.

Farcet MR, Kindermann J, Modrof J, Kreil TR. Farcet MR, et al. Among authors: modrof j. Transfusion. 2012 Jan;52(1):181-7. doi: 10.1111/j.1537-2995.2011.03251.x. Epub 2011 Jul 25. Transfusion. 2012. PMID: 21790623

9

Chikungunya virus and the safety of plasma products.

Leydold SM, Farcet MR, Kindermann J, Modrof J, Pölsler G, Berting A, Howard MK, Barrett PN, Kreil TR. Leydold SM, et al. Among authors: modrof j. Transfusion. 2012 Oct;52(10):2122-30. doi: 10.1111/j.1537-2995.2012.03565.x. Epub 2012 Feb 17. Transfusion. 2012. PMID: 22339168

10

Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine.

Lackner C, Leydold SM, Modrof J, Farcet MR, Grillberger L, Schäfer B, Anderle H, Kreil TR. Lackner C, et al. Among authors: modrof j. Vaccine. 2014 Apr 11;32(18):2056-61. doi: 10.1016/j.vaccine.2014.02.011. Epub 2014 Feb 20. Vaccine. 2014. PMID: 24560672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters